Klow80.
About Klow80
Klow80 is studied in dermatological and anti-aging research, e.g. in relation to skin and pigmentation models. In addition to the three mechanisms of the Glow combination, KPV adds a fourth, inflammation-related pathway via inhibition of NF-kB.
Research Application
Extends the Glow approach with a fourth, inflammation-related pathway via KPV. As with Glow70, no dedicated study exists for the full combination — the evidence relates to the four individual compounds.
Important to know
Claims circulating online are often not backed by valid clinical data. Treat all information as a starting point for your own scientific research, not as usage guidance.
Sequence and regulatory status data are based on publicly available sources and refer to the compound in general, not to a specific product.
Research Overview
The evidence base for skin and pigmentation peptides is largely based on preclinical and early clinical investigations.
- Dalmasso G, et al. Gastroenterology. 2008;134(1):166–178. PMID 18061177
- Hsieh MJ, et al. J Mol Med. 2017;95(3):323–333. PMID 27847966
- Pickart L, Margolina A. Int J Mol Sci. 2018;19(7):1987. PMID 29986520
References without a PMID can be located via the respective publisher. This overview does not claim to be exhaustive.
Question about Klow80?
We reply personally – via email or Telegram.